PASG
Passage BIO, Inc.
Company overview
- Market capitalization
- $15.04M
- Employees
- 24
- Latest publication
- 2026-09-29
About Passage BIO, Inc.
Passage Bio, Inc., a genetic medicines company, develops gene therapies for central nervous system diseases. It develops PBFT02, a functional granulin (GRN) and gene encoding progranulin (PGRN) for the treatment of FTD caused by progranulin deficiency; PBGM01, a functional GLB1 gene encoding ß-galactosidase for infantile GM1; and PBKR03, for the treatment of Krabbe disease. The company develops PBML04 for the treatment of metachromatic leukodystrophy; PBAL05 for the treatment of amyotrophic lateral sclerosis; and other programs for huntington's disease. It has a strategic research collaboration with the Trustees of the University of Pennsylvania's Gene Therapy Program; and collaboration agreement, and a development services and clinical supply agreement with Catalent Maryland, Inc. Passage Bio, Inc. was incorporated in 2017 and is based in Philadelphia, Pennsylvania.
Financial statements
Income Quarterly
| Metric | Q1 20262026-03-31 · USD | Q4 20252025-12-31 · USD | Q3 20252025-09-30 · USD | Q2 20252025-06-30 · USD | Q1 20252025-03-31 · USD | Q4 20242024-12-31 · USD | Q3 20242024-09-30 · USD | Q2 20242024-06-30 · USD |
|---|---|---|---|---|---|---|---|---|
| Total Revenue | 0USD | 0USD | 0USD | 0USD | 0USD | 3,212,000USD | 0USD | 0USD |
| Cost Of Revenue | 129,000USD | 177,000USD | — | 200,000USD | 201,000USD | 719,000USD | 800,000USD | 800,000USD |
| Gross Profit | -129,000USD | -177,000USD | — | -200,000USD | -201,000USD | -719,000USD | -800,000USD | -800,000USD |
| Research Development | 4,093,000USD | 5,418,000USD | 4,307,000USD | 5,814,000USD | 7,737,000USD | 9,558,000USD | 8,656,000USD | 10,430,000USD |
| Selling General Administrative | 4,787,000USD | 4,922,000USD | 4,348,000USD | 4,520,000USD | 6,085,000USD | 4,712,000USD | 7,251,000USD | 6,510,000USD |
| Total Operating Expenses | 8,751,000USD | 13,848,000USD | 8,655,000USD | 10,134,000USD | 16,459,000USD | 13,551,000USD | 20,702,000USD | 17,378,000USD |
| Operating Income | -8,880,000USD | -13,848,000USD | -8,655,000USD | -10,334,000USD | -16,459,000USD | -14,270,000USD | -20,702,000USD | -17,378,000USD |
| Interest Income | 300,000USD | — | — | — | 700,000USD | — | — | — |
| Net Interest Income | 300,000USD | — | — | — | 700,000USD | — | — | — |
| Income Before Tax | -7,559,000USD | -12,983,000USD | -7,749,000USD | -9,385,000USD | -15,405,000USD | -12,725,000USD | -19,340,000USD | -15,991,000USD |
| Net Income | -7,559,000USD | -12,983,000USD | -7,749,000USD | -9,385,000USD | -15,405,000USD | -12,725,000USD | -19,340,000USD | -15,991,000USD |
| Net Income From Continuing Ops | -7,559,000USD | -12,983,000USD | -7,749,000USD | -9,385,000USD | -15,405,000USD | -12,725,000USD | -19,340,000USD | -15,991,000USD |
| Ebit | -8,880,000USD | -10,340,000USD | -7,749,000USD | -9,385,000USD | -13,822,000USD | -13,025,000USD | -15,907,000USD | -16,940,000USD |
| Ebitda | -8,751,000USD | -10,163,000USD | -7,439,000USD | -9,185,000USD | -13,621,000USD | -12,306,000USD | -15,148,000USD | -16,143,000USD |
| Depreciation And Amortization | 129,000USD | 177,000USD | 310,000USD | 200,000USD | 201,000USD | 719,000USD | 759,000USD | 797,000USD |
| Reconciled Depreciation | 129,000USD | 177,000USD | 181,000USD | 169,000USD | 201,000USD | 719,000USD | 759,000USD | 797,000USD |
| Total Other Income Expense Net | 1,321,000USD | 865,000USD | 906,000USD | 949,000USD | 1,054,000USD | 1,545,000USD | 1,362,000USD | 1,387,000USD |
| Unclassified Operating Expenses | — | 3,508,000USD | — | — | 2,637,000USD | — | 4,795,000USD | — |
| Selling And Marketing Expenses | — | — | — | — | — | — | — | 800,000USD |
| Source | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy |
Income Yearly
| Metric | FY 20252025-12-31 · USD | FY 20242024-12-31 · USD | FY 20232023-12-31 · USD | FY 20222022-12-31 · USD | FY 20212021-12-31 · USD | FY 20202020-12-31 · USD | FY 20192019-12-31 · USD | FY 20182018-12-31 · USD |
|---|---|---|---|---|---|---|---|---|
| Total Revenue | 0USD | 0USD | 0USD | 0USD | 0USD | 0USD | 0USD | 0USD |
| Cost Of Revenue | 728,000USD | 3,081,000USD | 3,721,000USD | 3,679,000USD | 1,543,000USD | 800,000USD | 134,000USD | — |
| Gross Profit | -728,000USD | -3,081,000USD | -3,721,000USD | -3,679,000USD | -1,543,000USD | -800,000USD | -134,000USD | — |
| Research Development | 23,276,000USD | 40,179,000USD | 59,556,000USD | 86,053,000USD | 117,673,000USD | 82,788,000USD | 30,238,000USD | 9,167,000USD |
| Selling General Administrative | 19,875,000USD | 24,988,000USD | 41,580,000USD | 49,341,000USD | 60,056,000USD | 30,114,000USD | 6,951,000USD | 928,000USD |
| Total Operating Expenses | 42,423,000USD | 70,400,000USD | 96,415,000USD | 138,394,000USD | 185,729,000USD | 112,902,000USD | 37,189,000USD | 10,095,000USD |
| Operating Income | -43,151,000USD | -70,400,000USD | -100,136,000USD | -138,394,000USD | -185,729,000USD | -112,902,000USD | -37,189,000USD | -13,466,000USD |
| Income Before Tax | -45,522,000USD | -64,767,000USD | -102,062,000USD | -136,125,000USD | -185,386,000USD | -112,232,000USD | -45,634,000USD | -12,770,000USD |
| Net Income | -45,522,000USD | -64,767,000USD | -102,062,000USD | -136,125,000USD | -185,386,000USD | -112,232,000USD | -45,634,000USD | -12,770,000USD |
| Net Income From Continuing Ops | -45,522,000USD | -64,767,000USD | -112,375,000USD | -136,678,000USD | -185,787,000USD | -112,232,000USD | -45,634,000USD | -12,770,000USD |
| Ebit | -43,151,000USD | -65,167,000USD | -102,062,000USD | -135,394,000USD | -177,729,000USD | -111,902,000USD | -36,689,000USD | -22,865,000USD |
| Ebitda | -42,423,000USD | -62,086,000USD | -98,341,000USD | -131,715,000USD | -176,186,000USD | -111,102,000USD | -36,555,000USD | -7,420,000USD |
| Depreciation And Amortization | 728,000USD | 3,081,000USD | 3,721,000USD | 3,679,000USD | 1,543,000USD | 800,000USD | 134,000USD | 10,095,000USD |
| Reconciled Depreciation | 728,000USD | 3,081,000USD | 3,860,000USD | 3,679,000USD | 1,543,000USD | 800,000USD | 134,000USD | 0USD |
| Total Other Income Expense Net | -2,371,000USD | 5,633,000USD | -1,926,000USD | 2,269,000USD | 343,000USD | 670,000USD | -8,445,000USD | 696,000USD |
| Unclassified Operating Expenses | — | 5,233,000USD | -4,721,000USD | 3,000,000USD | 8,000,000USD | — | — | — |
| Income Tax Expense | — | -1USD | 5,390,000USD | 731,000USD | 6,114,000USD | -470,000USD | 8,945,000USD | -696,000USD |
| Interest Income | — | — | — | 2,269,000USD | 343,000USD | 670,000USD | 696,000USD | 0USD |
| Interest Expense | — | — | — | 2,269,000USD | 343,000USD | 670,000USD | 8,445,000USD | 696,000USD |
| Net Interest Income | — | — | — | 2,269,000USD | 343,000USD | 670,000USD | 696,000USD | 0USD |
| Non Operating Income Net Other | — | — | — | 1,716,000USD | -58,000USD | 670,000USD | — | — |
| Net Income Applicable To Common Shares | — | — | — | -136,125,000USD | -185,386,000USD | -112,232,000USD | -45,634,000USD | -12,770,000USD |
| Source | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy |
Balance sheet Quarterly
| Metric | Q1 20262026-03-31 · USD | Q4 20252025-12-31 · USD | Q3 20252025-09-30 · USD | Q2 20252025-06-30 · USD | Q1 20252025-03-31 · USD | Q4 20242024-12-31 · USD | Q3 20242024-09-30 · USD | Q2 20242024-06-30 · USD |
|---|---|---|---|---|---|---|---|---|
| Total Assets | 36,462,000USD | 62,281,000USD | 74,160,000USD | 79,198,000USD | 86,006,000USD | 102,412,000USD | 111,752,000USD | 125,392,000USD |
| Other Current Assets | 1,405,000USD | 1,459,000USD | 2,957,000USD | 2,689,000USD | 3,312,000USD | 2,059,000USD | 2,390,000USD | 3,227,000USD |
| Total Liab | 24,710,000USD | 43,526,000USD | 43,040,000USD | 40,940,000USD | 39,300,000USD | 41,151,000USD | 39,036,000USD | 34,835,000USD |
| Total Stockholder Equity | 11,752,000USD | 18,755,000USD | 31,120,000USD | 38,258,000USD | 46,706,000USD | 61,261,000USD | 72,716,000USD | 90,557,000USD |
| Other Current Liab | 17,645,000USD | 18,403,000USD | 17,751,000USD | 13,814,000USD | 12,726,000USD | 14,933,000USD | 11,729,000USD | 8,063,000USD |
| Capital Stock | 0USD | 0USD | 0USD | 0USD | 6,000USD | 6,000USD | 6,000USD | 6,000USD |
| Retained Earnings | -712,316,000USD | -704,757,000USD | -691,774,000USD | -684,025,000USD | -674,640,000USD | -659,235,000USD | -646,510,000USD | -627,170,000USD |
| Cash | 33,336,000USD | 46,303,000USD | 52,773,000USD | 57,626,000USD | 63,357,000USD | 37,573,000USD | 32,292,000USD | 24,770,000USD |
| Cash And Short Term Investments | 33,336,000USD | 46,303,000USD | 52,773,000USD | 57,626,000USD | 63,357,000USD | 76,756,000USD | 84,826,000USD | 91,773,000USD |
| Total Current Assets | 34,741,000USD | 47,762,000USD | 55,730,000USD | 60,315,000USD | 66,669,000USD | 78,815,000USD | 87,216,000USD | 95,000,000USD |
| Total Current Liabilities | 20,104,000USD | 23,083,000USD | 22,245,000USD | 19,801,000USD | 17,825,000USD | 19,363,000USD | 16,951,000USD | 12,385,000USD |
| Net Debt | -27,581,000USD | -22,293,000USD | -28,436,000USD | -32,895,000USD | -38,241,000USD | -12,097,000USD | -6,474,000USD | 1,381,000USD |
| Short Term Debt | 1,149,000USD | 3,567,000USD | 3,542,000USD | 3,592,000USD | 3,641,000USD | 3,688,000USD | 3,733,000USD | 3,701,000USD |
| Short Long Term Debt Total | 5,755,000USD | 24,010,000USD | 24,337,000USD | 24,731,000USD | 25,116,000USD | 25,476,000USD | 25,818,000USD | 26,151,000USD |
| Accounts Payable | 1,310,000USD | 1,113,000USD | 952,000USD | 2,395,000USD | 1,458,000USD | 742,000USD | 1,489,000USD | 621,000USD |
| Property Plant Equipment Net | 1,477,000USD | 14,275,000USD | 18,160,000USD | 18,613,000USD | 19,063,000USD | 23,134,000USD | 24,073,000USD | 29,876,000USD |
| Property Plant Equipment Gross | 3,535,000USD | 18,192,000USD | 21,901,000USD | 22,173,000USD | 22,440,000USD | 32,858,000USD | 33,079,000USD | 38,714,000USD |
| Common Stock Shares Outstanding | 3,205,866shares | 3,172,870shares | 3,168,933shares | 3,168,933shares | 3,105,500shares | 3,103,100shares | 3,088,150shares | 3,084,100shares |
| Non Current Assets Total | 1,721,000USD | 14,519,000USD | 18,430,000USD | 18,883,000USD | 19,337,000USD | 23,597,000USD | 24,536,000USD | 30,392,000USD |
| Non Current Liabilities Total | 4,606,000USD | 20,443,000USD | 20,795,000USD | 21,139,000USD | 21,475,000USD | 21,788,000USD | 22,085,000USD | 22,450,000USD |
| Non Currrent Assets Other | 244,000USD | 244,000USD | 270,000USD | 270,000USD | 274,000USD | 463,000USD | 463,000USD | 516,000USD |
| Net Working Capital | 14,637,000USD | 24,679,000USD | 33,485,000USD | 40,514,000USD | 48,844,000USD | 59,452,000USD | 70,265,000USD | 82,615,000USD |
| Unclassified Non Current Liabilities | 4,606,000USD | 20,443,000USD | 20,795,000USD | 21,139,000USD | 21,475,000USD | 21,788,000USD | 22,085,000USD | 22,450,000USD |
| Unclassified Equity | 724,068,000USD | 723,512,000USD | 722,894,000USD | 722,283,000USD | 721,334,000USD | 720,476,000USD | 719,182,000USD | 717,782,000USD |
| Short Term Investments | — | 0USD | 0USD | 0USD | 0USD | 39,183,000USD | 52,534,000USD | 67,003,000USD |
| Common Stock | — | — | — | — | 6,000USD | 6,000USD | 6,000USD | 6,000USD |
| Accumulated Other Comprehensive Income | — | — | — | — | — | 8,000USD | 32,000USD | -67,000USD |
| Other Assets | — | — | — | — | — | — | — | 1USD |
| Source | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy |
Balance sheet Yearly
| Metric | FY 20252025-12-31 · USD | FY 20242024-12-31 · USD | FY 20232023-12-31 · USD | FY 20222022-12-31 · USD | FY 20212021-12-31 · USD | FY 20202020-12-31 · USD | FY 20192019-12-31 · USD | FY 20182018-12-31 · USD |
|---|---|---|---|---|---|---|---|---|
| Total Assets | 62,281,000USD | 102,412,000USD | 150,545,000USD | 243,549,000USD | 355,076,000USD | 328,007,000USD | 178,613,000USD | 33,461,000USD |
| Other Current Assets | 1,459,000USD | 2,059,000USD | 3,665,000USD | 7,434,000USD | 9,293,000USD | 12,366,000USD | 6,901,000USD | 8,538,000USD |
| Total Liab | 43,526,000USD | 41,151,000USD | 39,262,000USD | 42,183,000USD | 36,419,000USD | 23,293,000USD | 4,261,000USD | 45,634,000USD |
| Total Stockholder Equity | 18,755,000USD | 61,261,000USD | 111,283,000USD | 201,366,000USD | 318,657,000USD | 304,714,000USD | 174,352,000USD | -12,173,000USD |
| Other Current Liab | 18,403,000USD | 14,933,000USD | 11,670,000USD | 11,011,000USD | 20,050,000USD | 15,910,000USD | 3,052,000USD | 95,000USD |
| Capital Stock | 0USD | 6,000USD | 5,000USD | 5,000USD | 5,000USD | 4,000USD | 3,000USD | 0USD |
| Retained Earnings | -704,757,000USD | -659,235,000USD | -594,468,000USD | -492,406,000USD | -356,281,000USD | -170,895,000USD | -58,663,000USD | -13,029,000USD |
| Cash | 46,303,000USD | 37,573,000USD | 21,709,000USD | 34,601,000USD | 128,965,000USD | 135,002,000USD | 158,874,000USD | 24,861,000USD |
| Cash And Short Term Investments | 46,303,000USD | 76,756,000USD | 114,294,000USD | 189,610,000USD | 315,773,000USD | 304,817,000USD | 158,874,000USD | 24,861,000USD |
| Total Current Assets | 47,762,000USD | 78,815,000USD | 117,959,000USD | 197,044,000USD | 325,066,000USD | 317,183,000USD | 165,775,000USD | 33,399,000USD |
| Total Current Liabilities | 23,083,000USD | 19,363,000USD | 16,341,000USD | 18,351,000USD | 29,498,000USD | 21,175,000USD | 3,681,000USD | 307,000USD |
| Net Debt | -22,293,000USD | -12,097,000USD | 4,585,000USD | -7,494,000USD | -128,965,000USD | -135,002,000USD | -158,874,000USD | -24,861,000USD |
| Short Term Debt | 3,567,000USD | 3,688,000USD | 3,373,000USD | 3,275,000USD | — | — | — | — |
| Short Long Term Debt Total | 24,010,000USD | 25,476,000USD | 26,294,000USD | 27,107,000USD | — | — | — | — |
| Short Term Investments | 0USD | 39,183,000USD | 92,585,000USD | 155,009,000USD | 186,808,000USD | 169,815,000USD | — | — |
| Accounts Payable | 1,113,000USD | 742,000USD | 1,298,000USD | 4,065,000USD | 9,448,000USD | 5,265,000USD | 629,000USD | 212,000USD |
| Property Plant Equipment Net | 14,275,000USD | 23,134,000USD | 32,153,000USD | 42,238,000USD | 23,806,000USD | 2,795,000USD | 1,087,000USD | 28,000USD |
| Property Plant Equipment Gross | 18,192,000USD | 32,858,000USD | 39,389,000USD | 22,515,000USD | 23,806,000USD | 2,795,000USD | 1,087,000USD | 28,000USD |
| Common Stock Shares Outstanding | 3,172,870shares | 3,020,250shares | 2,737,150shares | 2,721,451shares | 2,667,200shares | 2,280,750shares | 1,198,150shares | 1,198,150shares |
| Non Current Assets Total | 14,519,000USD | 23,597,000USD | 32,586,000USD | 46,505,000USD | 30,010,000USD | 8,029,000USD | 12,838,000USD | 62,000USD |
| Non Current Liabilities Total | 20,443,000USD | 21,788,000USD | 22,921,000USD | 23,832,000USD | 6,921,000USD | 2,118,000USD | 580,000USD | 45,327,000USD |
| Non Currrent Assets Other | 244,000USD | 463,000USD | 433,000USD | 4,267,000USD | 6,204,000USD | 5,234,000USD | 11,751,000USD | 34,000USD |
| Net Working Capital | 24,679,000USD | 59,452,000USD | 101,618,000USD | 178,693,000USD | 295,568,000USD | 296,008,000USD | 162,094,000USD | 33,092,000USD |
| Unclassified Non Current Liabilities | 20,443,000USD | 21,788,000USD | 22,921,000USD | 23,832,000USD | — | — | -1,776,000USD | 43,118,000USD |
| Unclassified Equity | 723,512,000USD | 720,476,000USD | 705,784,000USD | 694,728,000USD | 675,341,000USD | 475,613,000USD | 233,239,605USD | — |
| Common Stock | — | 6,000USD | 5,000USD | 5,000USD | 5,000USD | 4,000USD | 3,000USD | 2,000USD |
| Accumulated Other Comprehensive Income | — | 8,000USD | -43,000USD | -966,000USD | -413,000USD | -12,000USD | -230,605USD | 0USD |
| Other Assets | — | — | 1USD | 4,267,000USD | 0USD | 2,795,000USD | 11,751,000USD | 34,000USD |
| Net Receivables | — | — | — | 4,267,000USD | 6,204,000USD | 8,029,000USD | — | — |
| Net Tangible Assets | — | — | — | 201,366,000USD | 318,657,000USD | 304,714,000USD | -56,253,000USD | -12,173,000USD |
| Unclassified Current Assets | — | — | — | -4,267,000USD | -6,204,000USD | -8,029,000USD | — | — |
| Unclassified Non Current Assets | — | — | — | -4,267,000USD | — | -2,795,000USD | -11,751,000USD | — |
| Other Liab | — | — | — | — | 6,921,000USD | 2,118,000USD | 580,000USD | 2,209,000USD |
| Deferred Long Term Liab | — | — | — | — | — | 200,000USD | 1,700,000USD | — |
| Non Current Liabilities Other | — | — | — | — | — | 41,000USD | 76,000USD | — |
| Source | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy |
Cash flow Quarterly
| Metric | Q1 20262026-03-31 · USD | Q4 20252025-12-31 · USD | Q3 20252025-09-30 · USD | Q2 20252025-06-30 · USD | Q1 20252025-03-31 · USD | Q4 20242024-12-31 · USD | Q3 20242024-09-30 · USD | Q2 20242024-06-30 · USD |
|---|---|---|---|---|---|---|---|---|
| Net Income | -7,559,000USD | -12,983,000USD | -7,749,000USD | -9,385,000USD | -15,405,000USD | -12,725,000USD | -19,340,000USD | -15,991,000USD |
| Depreciation | 129,000USD | 177,000USD | 200,000USD | 169,000USD | 201,000USD | 719,000USD | 759,000USD | 797,000USD |
| Stock Based Compensation | 556,000USD | 609,000USD | 611,000USD | 923,000USD | 858,000USD | 1,247,000USD | 1,400,000USD | 1,578,000USD |
| Other Non Cash Items | -77,000USD | -507,000USD | 592,000USD | 14,000USD | 2,766,000USD | -365,000USD | 4,374,000USD | 141,000USD |
| Change In Working Capital | -5,480,000USD | 6,225,000USD | 2,104,000USD | 1,949,000USD | -2,267,000USD | 2,680,000USD | 5,360,000USD | 339,000USD |
| Total Cash From Operating Activities | -12,987,000USD | -6,479,000USD | -4,853,000USD | -6,330,000USD | -13,847,000USD | -8,444,000USD | -7,447,000USD | -13,136,000USD |
| Capital Expenditures | 0USD | 0USD | 0USD | 0USD | 0USD | -14,000USD | -20,000USD | 0USD |
| Free Cash Flow | -12,987,000USD | -6,479,000USD | -4,853,000USD | -6,330,000USD | -13,847,000USD | -8,458,000USD | -7,467,000USD | -13,136,000USD |
| Investments | 0USD | 0USD | 0USD | 585,000USD | 39,631,000USD | 13,678,000USD | 14,969,000USD | 1,048,000USD |
| Total Cashflows From Investing Activities | 20,000USD | 1,170,000USD | — | 585,000USD | 39,631,000USD | 13,678,000USD | 14,969,000USD | 1,048,000USD |
| Change In Cash | -12,967,000USD | -6,470,000USD | -4,853,000USD | -5,731,000USD | 25,784,000USD | 5,281,000USD | 7,522,000USD | -12,003,000USD |
| Begin Period Cash Flow | 46,303,000USD | 52,773,000USD | 57,626,000USD | 63,357,000USD | 37,573,000USD | 32,292,000USD | 24,770,000USD | 36,773,000USD |
| End Period Cash Flow | 33,336,000USD | 46,303,000USD | 52,773,000USD | 57,626,000USD | 63,357,000USD | 37,573,000USD | 32,292,000USD | 24,770,000USD |
| Total Cash From Financing Activities | — | 9,000USD | 0USD | 14,000USD | 0USD | 47,000USD | 0USD | 85,000USD |
| Sale Purchase Of Stock | — | 9,000USD | — | 14,000USD | — | 47,000USD | 50,000USD | — |
| Issuance Of Capital Stock | — | 0USD | 0USD | 0USD | 0USD | 0USD | 0USD | 50,000USD |
| Other Cashflows From Financing Activities | — | 9,000USD | — | — | — | 8,839,000USD | 14,969,000USD | 35,000USD |
| Unclassified Investing Cash Flow | — | 1,170,000USD | — | — | — | — | — | — |
| Other Cashflows From Investing Activities | — | — | — | — | 585,000USD | — | — | — |
| Unclassified Financing Cash Flow | — | — | — | — | — | -8,839,000USD | -15,019,000USD | — |
| Source | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy |
Cash flow Yearly
| Metric | FY 20252025-12-31 · USD | FY 20242024-12-31 · USD | FY 20232023-12-31 · USD | FY 20222022-12-31 · USD | FY 20212021-12-31 · USD | FY 20202020-12-31 · USD | FY 20192019-12-31 · USD | FY 20182018-12-31 · USD |
|---|---|---|---|---|---|---|---|---|
| Net Income | -45,522,000USD | -64,767,000USD | -102,062,000USD | -136,125,000USD | -185,386,000USD | -112,232,000USD | -45,634,000USD | -12,770,000USD |
| Depreciation | 857,000USD | 3,081,000USD | 3,721,000USD | 3,679,000USD | 1,543,000USD | 800,000USD | 134,000USD | 134,000USD |
| Stock Based Compensation | 3,001,000USD | 5,820,000USD | 10,921,000USD | 18,954,000USD | 32,691,000USD | 14,580,000USD | 1,454,000USD | — |
| Other Non Cash Items | 6,159,000USD | 3,706,000USD | 3,817,000USD | 3,773,000USD | 10,075,000USD | 1,259,000USD | 10,093,000USD | 2,727,000USD |
| Change In Working Capital | 3,996,000USD | 4,204,000USD | 5,339,000USD | -8,491,000USD | 11,420,000USD | 14,440,000USD | -5,943,000USD | -8,524,000USD |
| Total Cash From Operating Activities | -31,509,000USD | -47,956,000USD | -78,264,000USD | -118,210,000USD | -126,879,000USD | -80,520,000USD | -39,896,000USD | -18,567,000USD |
| Capital Expenditures | 0USD | -34,000USD | -146,000USD | -5,274,000USD | -25,642,000USD | -1,646,000USD | -1,693,000USD | -2,543,000USD |
| Free Cash Flow | -31,509,000USD | -47,990,000USD | -78,410,000USD | -123,484,000USD | -152,521,000USD | -82,166,000USD | -41,589,000USD | -21,110,000USD |
| Investments | 39,046,000USD | 54,946,000USD | 54,279,000USD | 30,473,000USD | -20,172,000USD | -170,460,000USD | -170,460,000USD | -2,543,000USD |
| Total Cashflows From Investing Activities | 40,216,000USD | 54,946,000USD | 65,237,000USD | 25,199,000USD | -45,814,000USD | -172,106,000USD | -1,693,000USD | -2,543,000USD |
| Total Cash From Financing Activities | 23,000USD | 8,874,000USD | 135,000USD | -1,353,000USD | 166,656,000USD | 228,754,000USD | 175,602,000USD | 45,971,000USD |
| Sale Purchase Of Stock | 23,000USD | 97,000USD | 135,000USD | 304,000USD | 887,000USD | 284,000USD | — | — |
| Issuance Of Capital Stock | 0USD | 8,742,000USD | 150,000USD | 626,000USD | 165,806,000USD | 228,262,000USD | 176,189,000USD | 45,971,000USD |
| Change In Cash | 8,730,000USD | 15,864,000USD | -12,892,000USD | -94,364,000USD | -6,037,000USD | -23,872,000USD | 134,013,000USD | 24,861,000USD |
| Begin Period Cash Flow | 37,573,000USD | 21,709,000USD | 34,601,000USD | 128,965,000USD | 135,002,000USD | 158,874,000USD | 24,861,000USD | 0USD |
| End Period Cash Flow | 46,303,000USD | 37,573,000USD | 21,709,000USD | 34,601,000USD | 128,965,000USD | 135,002,000USD | 158,874,000USD | 24,861,000USD |
| Other Cashflows From Investing Activities | 1,170,000USD | — | -1USD | -3,000,000USD | -8,000,000USD | -500,000USD | -500,000USD | -2,515USD |
| Other Cashflows From Financing Activities | 23,000USD | 132,000USD | 65,237,000USD | -1,786,000USD | -37,000USD | 284,000USD | 175,602,000USD | 45,971,000USD |
| Unclassified Financing Cash Flow | — | 8,645,000USD | -65,237,000USD | — | 165,806,000USD | 228,186,000USD | -176,189,000USD | -45,971,000USD |
| Unclassified Investing Cash Flow | — | — | 11,104,001USD | 3,000,000USD | 8,000,000USD | — | 170,960,000USD | 2,545,515USD |
| Change To Liabilities | — | — | — | -12,750,000USD | 6,184,000USD | 16,785,000USD | 398,000USD | 212,000USD |
| Cash And Cash Equivalents Changes | — | — | — | -94,364,000USD | -6,037,000USD | -23,872,000USD | — | — |
| Unclassified Operating Cash Flow | — | — | — | — | 2,778,000USD | — | — | — |
| Change To Account Receivables | — | — | — | — | — | — | 398,000USD | 212,000USD |
| Source | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy |
Operating metrics
No operating metrics are currently published for this company.
Revenue breakdown
No revenue breakdown is currently published for this company.
Periods follow company fiscal calendars. Quarterly, annual and year-to-date amounts are shown separately. Missing values are not zero. Data may be delayed, incomplete or corrected; follow the disclosure links to verify figures.